Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on June 10, 2026

Jun. 10, 2026

Pioneering evidence shows how entrepreneurship model can reduce extreme poverty among refugees

Indeterminate GlobeNewswire

Jun. 10, 2026

Beyond Air, Inc. Urges Stockholders to Vote “FOR” All Proposals Ahead of the Upcoming Special Meeting

Indeterminate GlobeNewswire

Jun. 10, 2026

Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL

Indeterminate GlobeNewswire

Jun. 10, 2026

Senseonics and Welldoc Partner to Develop Next-Generation App for Eversense® 365

Indeterminate GlobeNewswire

Jun. 10, 2026

Profusa Issues Letter to Shareholders Encouraging Shareholders to Vote FOR All Proposals at June 23, 2026 Annual Meeting

Indeterminate GlobeNewswire

Jun. 10, 2026

RadioMedix Announces Receiving FDA Approval of its Generic Ga-68 PSMA-11 Radiodiagnostic for Prostate Cancer

Indeterminate GlobeNewswire

Jun. 10, 2026

Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.

Indeterminate GlobeNewswire

Jun. 10, 2026

Akebia Therapeutics Strengthens Vafseo® (vadadustat) Patent Portfolio

Indeterminate GlobeNewswire

Jun. 10, 2026

Parexel to Showcase Seven Research Posters and Debut New Hematology Playbook at the European Hematology Association Congress 2026

Indeterminate GlobeNewswire

Jun. 10, 2026

Polyrizon Receives Notice of European Patent Publication for Innovative Mucoadhesive Nasal Drug Delivery Technology

Indeterminate GlobeNewswire

Jun. 10, 2026

Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success

Indeterminate GlobeNewswire

Jun. 10, 2026

Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases

Indeterminate GlobeNewswire

Jun. 10, 2026

Tris Pharma Announces FDA Grant of Orphan Drug Designation for TRN-257 (Oxybate for Extended-Release Oral Suspension) a Once-Nightly, Low-Sodium Oxybate Product for Idiopathic Hypersomnia

Indeterminate GlobeNewswire

Jun. 10, 2026

Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C

Indeterminate GlobeNewswire

Jun. 10, 2026

CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies

Indeterminate GlobeNewswire

Jun. 10, 2026

Senior Dog Joint Supplements: What Veterinarians Look For

Indeterminate GlobeNewswire

Jun. 10, 2026

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Indeterminate GlobeNewswire

Jun. 10, 2026

Ligand Announces 2026 Investor Day in New York City

Indeterminate GlobeNewswire

Jun. 10, 2026

Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease

Indeterminate GlobeNewswire

Jun. 10, 2026

Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit

Indeterminate GlobeNewswire